01 5Vyxeos
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 121
2019 Revenue in Millions : 121
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 134
2020 Revenue in Millions : 121
Growth (%) : 11
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 128
2021 Revenue in Millions : 134
Growth (%) : -5
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 147
2022 Revenue in Millions : 128
Growth (%) : 15
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 121
2018 Revenue in Millions : 101
Growth (%) : 20
LOOKING FOR A SUPPLIER?